Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 7857345, 8 pages
http://dx.doi.org/10.1155/2016/7857345
Research Article

A Comparison of the Effects of Neuronal Nitric Oxide Synthase and Inducible Nitric Oxide Synthase Inhibition on Cartilage Damage

1Istanbul Esenyurt University, 34510 Istanbul, Turkey
2Department of Pharmacovigilance, Materiovigilance and Rational Use of Drugs, Tekirdag State Hospital, Ministry of Health, 59100 Tekirdag, Turkey
3Kanuni Sultan Suleyman Training and Research Hospital, Turgut Ozal Street No. 1, Halkali, Kucukcekmece, 34303 Istanbul, Turkey
4Istanbul University, Cerrahpasa School of Medicine, Department of Pathology, Istanbul University, 34098 Istanbul, Turkey
5Nisantasi University, 34360 Istanbul, Turkey
6Department of Anesthesiology and Reanimation, Acıbadem University, 34360 Istanbul, Turkey

Received 14 March 2016; Revised 3 May 2016; Accepted 16 May 2016

Academic Editor: Patrizia Rovere-Querini

Copyright © 2016 Nevzat Selim Gokay et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Jang and G. A. C. Murrell, “Nitric oxide in arthritis,” Free Radical Biology and Medicine, vol. 24, no. 9, pp. 1511–1519, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. K. D. Brandt, C. W. Slemenda, and A. Osteoarthritis, “Epidemiology, pathology and pathophysiology,” in Primer on the Rheumatic Diseases, H. R. Schumacher, J. H. Klippel, and W. J. Koopman, Eds., Arthritis Foundation, Atlanta, Ga, USA, 1993. View at Google Scholar
  3. C. I. Westacott and M. Sharif, “Cytokines in osteoarthritis: mediators or markers of joint destruction?” Seminars in Arthritis and Rheumatism, vol. 25, no. 4, pp. 254–272, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Vuolteenaho, T. Moilanen, N. Al-Saffar, R. G. Knowles, and E. Moilanen, “Regulation of the nitric oxide production resulting from the glucocorticoid-insensitive expression of iNOS in human osteoarthritic cartilage,” Osteoarthritis and Cartilage, vol. 9, no. 7, pp. 597–605, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. M. L. Tiku, S. Gupta, and D. R. Deshmukh, “Aggrecan degradation in chondrocytes is mediated by reactive oxygen species and protected by antioxidants,” Free Radical Research, vol. 30, no. 5, pp. 395–405, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. R. M. Clancy, A. R. Amin, and S. B. Abramson, “The role of nitric oxide in inflammation and immunity,” Arthritis and Rheumatism, vol. 41, no. 7, pp. 1141–1151, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. E. W. St Clair, “Nitric oxide—friend or foe in arthritis?” Journal of Rheumatology, vol. 25, no. 8, pp. 1451–1453, 1998. View at Google Scholar · View at Scopus
  8. A. Karan, M. A. Karan, P. Vural et al., “Synovial fluid nitric oxide levels in patients with knee osteoarthritis,” Clinical Rheumatology, vol. 22, no. 6, pp. 397–399, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Casagrande, J. P. Stains, and A. M. Murthi, “Identification of shoulder osteoarthritis biomarkers: comparison between shoulders with and without osteoarthritis,” Journal of Shoulder and Elbow Surgery, vol. 24, no. 3, pp. 382–390, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Balaganur, N. N. Pathak, M. C. Lingaraju et al., “Effect of S-methylisothiourea, an inducible nitric oxide synthase inhibitor, in joint pain and pathology in surgically induced model of osteoarthritis,” Connective Tissue Research, vol. 55, no. 5-6, pp. 367–377, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M.-P. H. Le Graverand, R. S. Clemmer, P. Redifer et al., “A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee,” Annals of the Rheumatic Diseases, vol. 72, no. 2, pp. 187–195, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S. B. Abramson, “Osteoarthritis and nitric oxide,” Osteoarthritis and Cartilage, vol. 16, no. 2, pp. S15–S20, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Pozza, C. Bettelli, F. Magnani, M. T. Mascia, E. Manzini, and L. Calzà, “Is neuronal nitric oxide involved in adjuvant-induced joint inflammation?” European Journal of Pharmacology, vol. 359, no. 1, pp. 87–93, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Ramage, M.-A. Martel, G. E. Hardingham, and D. M. Salter, “NMDA receptor expression and activity in osteoarthritic human articular chondrocytes,” Osteoarthritis and Cartilage, vol. 16, no. 12, pp. 1576–1584, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Kettunen and P. Rokkanen, “The repair of a full thickness articular defect. An experimental study on growing rats,” Annales Chirurgiae et Gynaecologiae, vol. 62, no. 3, pp. 166–168, 1973. View at Google Scholar · View at Scopus
  16. S. Mendelson, P. Wooley, D. Lucas, and D. Markel, “The effect of hyaluronic acid on a rabbit model of full-thickness cartilage repair,” Clinical Orthopaedics and Related Research, no. 424, pp. 266–271, 2004. View at Google Scholar · View at Scopus
  17. D. M. Knapik, R. K. Harrison, R. A. Siston, S. Agarwal, and D. C. Flanigan, “Impact of lesion location on the progression of osteoarthritis in a rat knee model,” Journal of Orthopaedic Research, vol. 33, no. 2, pp. 237–245, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. B. E. Gencosmanoglu, M. Eryavuz, and S. Dervisoglu, “Effects of some nonsteroidal anti-inflammatory drugs on articular cartilage of rats in an experimental model of osteoarthritis,” Research in Experimental Medicine, vol. 200, no. 3, pp. 215–226, 2001. View at Google Scholar · View at Scopus
  19. R. R. Castro, F. Q. Cunha, F. S. Silva Jr., and F. A. C. Rocha, “A quantitative approach to measure joint pain in experimental osteoarthritis—evidence of a role for nitric oxide,” Osteoarthritis and Cartilage, vol. 14, no. 8, pp. 769–776, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Gerwin, A. M. Bendele, S. Glasson, and C. S. Carlson, “The OARSI histopathology initiative—recommendations for histological assessments of osteoarthritis in the rat,” Osteoarthritis and Cartilage, vol. 18, supplement 3, pp. S24–S34, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Martel-Pelletier, “Pathophysiology of osteoarthritis,” Osteoarthritis and Cartilage, vol. 6, no. 6, pp. 374–376, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. Q. Yan, Q. Feng, and F. Beier, “Endothelial nitric oxide synthase deficiency in mice results in reduced chondrocyte proliferation and endochondral bone growth,” Arthritis & Rheumatism, vol. 62, no. 7, pp. 2013–2022, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Q. Yan, Q. Feng, and F. Beier, “Reduced chondrocyte proliferation, earlier cell cycle exit and increased apoptosis in neuronal nitric oxide synthase-deficient mice,” Osteoarthritis and Cartilage, vol. 20, no. 2, pp. 144–151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. A. K. Nussler, M. Di Silvio, T. R. Billiar et al., “Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin,” Journal of Experimental Medicine, vol. 176, no. 1, pp. 261–264, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. A. R. Amin, M. Attur, and S. B. Abramson, “Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis,” Current Opinion in Rheumatology, vol. 11, no. 3, pp. 202–209, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Melchiorri, R. Meliconi, L. Frizziero et al., “Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis,” Arthritis and Rheumatism, vol. 41, no. 12, pp. 2165–2174, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Mazzetti, B. Grigolo, L. Pulsatelli et al., “Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis,” Clinical Science, vol. 101, no. 6, pp. 593–599, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. A. R. Amin, P. E. Di Cesare, P. Vyas et al., “The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase,” Journal of Experimental Medicine, vol. 182, no. 6, pp. 2097–2102, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Sakurai, H. Kohsaka, M.-F. Liu et al., “Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides,” The Journal of Clinical Investigation, vol. 96, no. 5, pp. 2357–2363, 1995. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Stadler, M. Stefanovic-Racic, T. R. Billiar et al., “Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide,” Journal of Immunology, vol. 147, no. 11, pp. 3915–3920, 1991. View at Google Scholar · View at Scopus
  31. B. Fermor, J. B. Weinberg, D. S. Pisetsky, M. A. Misukonis, A. J. Banes, and F. Guilak, “The effects of static and intermittent compression on nitric oxide production in articular cartilage explants,” Journal of Orthopaedic Research, vol. 19, no. 4, pp. 729–737, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. J.-P. Pelletier, F. Mineau, P. Ranger, G. Tardif, and J. Martel-Pelletier, “The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation,” Osteoarthritis and Cartilage, vol. 4, no. 1, pp. 77–84, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. J. P. Pelletier, F. Mineau, P. Ranger, and J. Martel-Pelletier, “The synthesis of nitric oxide induced by IL-1 in human chondrocytes markedly reduced the synthesis of IL-1 receptor antagonist (IL-1 ra): a possible role in osteoarthritic cartilage degradation,” Transactions of the Orthopaedic Research Society, vol. 20, article 352, 1995. View at Google Scholar
  34. G. A. C. Murrell, D. Jang, and R. J. Williams, “Nitric oxide activates metalloprotease enzymes in articular cartilage,” Biochemical and Biophysical Research Communications, vol. 206, no. 1, pp. 15–21, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Boileau, J. Martel-Pelletier, F. Moldovan et al., “The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide,” Arthritis and Rheumatism, vol. 46, no. 10, pp. 2637–2647, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Hashimoto, K. Takahashi, D. Amiel, R. D. Coutts, and M. Lotz, “Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis,” Arthritis and Rheumatism, vol. 41, no. 7, pp. 1266–1274, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. D. M. Visco, D. S. Fletcher, C. J. Orevillo et al., “NOS 2 deficient mice are susceptible to collagen-induced arthritis,” NOS, vol. 43, p. 416, 1997. View at Google Scholar
  38. M. Stefanovic-Racic, T. I. Morales, D. Taskiran, L. A. McIntyre, and C. H. Evans, “The role of nitric oxide in proteoglycan turnover by bovine articular cartilage organ cultures,” Journal of Immunology, vol. 156, no. 3, pp. 1213–1220, 1996. View at Google Scholar · View at Scopus
  39. T. Tamura, T. Nakanishi, Y. Kimura et al., “Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis,” Endocrinology, vol. 137, no. 9, pp. 3729–3737, 1996. View at Publisher · View at Google Scholar · View at Scopus
  40. H. J. Häuselmann, M. Stefanovic-Racic, B. A. Michel, and C. H. Evans, “Differences in nitric oxide production by superficial and deep human articular chondrocytes: implications for proteoglycan turnover in inflammatory joint diseases,” Journal of Immunology, vol. 160, no. 3, pp. 1444–1448, 1998. View at Google Scholar · View at Scopus
  41. M. M. Bezerra, S. D. Brain, S. Greenacre et al., “Reactive nitrogen species scavenging, rather than nitric oxide inhibition, protects from articular cartilage damage in rat zymosan-induced arthritis,” British Journal of Pharmacology, vol. 141, no. 1, pp. 172–182, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Paolucci, P. Rovere, C. De Nadai, A. A. Manfredi, and E. Clementi, “Nitric oxide inhibits the tumor necrosis factor α-regulated endocytosis of human dendritic cells in a cyclic GMP-dependent way,” Journal of Biological Chemistry, vol. 275, no. 26, pp. 19638–19644, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Falcone, C. Perrotta, C. D. Palma et al., “Activation of acid sphingomyelinase and its inhibition by the nitric oxide/cyclic guanosine 3′,5′-monophosphate pathway: key events in Escherichia coli-elicited apoptosis of dendritic cells,” The Journal of Immunology, vol. 173, no. 7, pp. 4452–4463, 2004. View at Publisher · View at Google Scholar · View at Scopus